デフォルト表紙
市場調査レポート
商品コード
1430378

感染症の体外検査の世界市場に関する洞察、2030年までの予測

Global In Vitro Testing for Infectious Diseases Market Insights, Forecast to 2030

出版日: | 発行: QYResearch | ページ情報: 英文 127 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
感染症の体外検査の世界市場に関する洞察、2030年までの予測
出版日: 2024年02月22日
発行: QYResearch
ページ情報: 英文 127 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、感染症の体外検査 (In Vitro Testing for Infectious Diseases) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の感染症の体外検査の市場規模成長率:タイプ別, 2019 VS 2023 VS 2030
    • Consumables
    • Equipment
  • 市場:用途別
    • 世界の感染症の体外検査の市場規模成長率:用途別, 2019 VS 2023 VS 2030
    • Hepatitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の感染症の体外検査の市場展望 (2019-2030)
  • 世界の感染症の体外検査の市場成長トレンド:地域別
    • 感染症の体外検査 市場規模:地域別: 2019 VS 2023 VS 2030
    • 感染症の体外検査の市場規模実績:地域別 (2019-2024)
    • 感染症の体外検査の市場規模予測:地域別 (2025-2030)
  • 感染症の体外検査 市場動向
    • 感染症の体外検査 業界動向
    • 感染症の体外検査 市場の促進要因
    • 感染症の体外検査 市場の課題
    • 感染症の体外検査 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界規模の売上高 感染症の体外検査 :競合別
    • 世界の感染症の体外検査の収益:企業別 (2019-2024)
    • 世界の感染症の体外検査の収益シェア:企業別 (2019-2024)
  • 世界の感染症の体外検査の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 感染症の体外検査, 売上高ランキング, 2022 VS 2023 VS 2024
  • 世界の感染症の体外検査 市場集中度
    • 世界の感染症の体外検査 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 感染症の体外検査の収益 2023
  • 世界の主要企業 感染症の体外検査 本社 および提供地域
  • 世界の主要企業 感染症の体外検査, 製品およびアプリケーション
  • 世界の主要企業 感染症の体外検査, 業界参入時期
  • M&A, 拡張計画

第4章 感染症の体外検査 内訳データ:タイプ別

  • 世界の感染症の体外検査の市場規模実績:タイプ別 (2019-2024)
  • 世界の感染症の体外検査の市場規模予測:タイプ別 (2025-2030)

第5章 感染症の体外検査 内訳データ:用途別

  • 世界の感染症の体外検査の市場規模実績:用途別 (2019-2024)
  • 世界の感染症の体外検査の市場規模予測:用途別 (2025-2030)

第6章 北米

  • 北米の感染症の体外検査 市場規模 (2019-2030)
  • 北米の感染症の体外検査 市場規模:タイプ別
    • 北米の感染症の体外検査 市場規模:タイプ別 (2019-2024)
    • 北米の感染症の体外検査 市場規模:タイプ別 (2025-2030)
    • 北米の感染症の体外検査の市場シェア:タイプ別 (2019-2030)
  • 北米の感染症の体外検査 市場規模:用途別
    • 北米の感染症の体外検査 市場規模:用途別 (2019-2024)
    • 北米の感染症の体外検査 市場規模:用途別 (2025-2030)
    • 北米の感染症の体外検査の市場シェア:用途別 (2019-2030)
  • 北米の感染症の体外検査 市場規模:国別
    • 北米の感染症の体外検査 市場規模:国別: 2019 VS 2023 VS 2030
    • 北米の感染症の体外検査 市場規模:国別 (2019-2024)
    • 北米の感染症の体外検査 市場規模:国別 (2025-2030)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の感染症の体外検査 市場規模 (2019-2030)
  • 欧州の感染症の体外検査 市場規模:タイプ別
    • 欧州の感染症の体外検査 市場規模:タイプ別 (2019-2024)
    • 欧州の感染症の体外検査 市場規模:タイプ別 (2025-2030)
    • 欧州の感染症の体外検査の市場シェア:タイプ別 (2019-2030)
  • 欧州の感染症の体外検査 市場規模:用途別
    • 欧州の感染症の体外検査 市場規模:用途別 (2019-2024)
    • 欧州の感染症の体外検査 市場規模:用途別 (2025-2030)
    • 欧州の感染症の体外検査の市場シェア:用途別 (2019-2030)
  • 欧州の感染症の体外検査 市場規模:国別
    • 欧州の感染症の体外検査 市場規模:国別: 2019 VS 2023 VS 2030
    • 欧州の感染症の体外検査 市場規模:国別 (2019-2024)
    • 欧州の感染症の体外検査 市場規模:国別 (2025-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の感染症の体外検査 市場規模 (2019-2030)
  • 中国の感染症の体外検査 市場規模:タイプ別
    • 中国の感染症の体外検査 市場規模:タイプ別 (2019-2024)
    • 中国の感染症の体外検査 市場規模:タイプ別 (2025-2030)
    • 中国の感染症の体外検査の市場シェア:タイプ別 (2019-2030)
  • 中国の感染症の体外検査 市場規模:用途別
    • 中国の感染症の体外検査 市場規模:用途別 (2019-2024)
    • 中国の感染症の体外検査 市場規模:用途別 (2025-2030)
    • 中国の感染症の体外検査の市場シェア:用途別 (2019-2030)

第9章 アジア(中国を除く)

  • アジア地域 感染症の体外検査 市場規模 (2019-2030)
  • アジア地域 感染症の体外検査 市場規模:タイプ別
    • アジア地域 感染症の体外検査 市場規模:タイプ別 (2019-2024)
    • アジア地域 感染症の体外検査 市場規模:タイプ別 (2025-2030)
    • アジア地域 感染症の体外検査の市場シェア:タイプ別 (2019-2030)
  • アジア地域 感染症の体外検査 市場規模:用途別
    • アジア地域 感染症の体外検査 市場規模:用途別 (2019-2024)
    • アジア地域 感染症の体外検査 市場規模:用途別 (2025-2030)
    • アジア地域 感染症の体外検査の市場シェア:用途別 (2019-2030)
  • アジア地域 感染症の体外検査 市場規模:地域別
    • アジア地域 感染症の体外検査 市場規模:地域別: 2019 VS 2023 VS 2030
    • アジア地域 感染症の体外検査 市場規模:地域別 (2019-2024)
    • アジア地域 感染症の体外検査 市場規模:地域別 (2025-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 感染症の体外検査 市場規模 (2019-2030)
  • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:タイプ別
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:タイプ別 (2019-2024)
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:タイプ別 (2025-2030)
    • 中近東・アフリカ・中南米 感染症の体外検査の市場シェア:タイプ別 (2019-2030)
  • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:用途別
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:用途別 (2019-2024)
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:用途別 (2025-2030)
    • 中近東・アフリカ・中南米 感染症の体外検査の市場シェア:用途別 (2019-2030)
  • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:国別
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:国別: 2019 VS 2023 VS 2030
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:国別 (2019-2024)
    • 中近東・アフリカ・中南米 感染症の体外検査 市場規模:国別 (2025-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • KHB
  • Daan Gene
  • Leadman
  • Zhongsheng
  • Bsbe
  • Maccura
  • Hitachi
  • Canon
  • Sysmex
  • Auto Bio
  • Mindray
  • Bgi
  • Wondfo

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
  • Table 2. Key Players of Consumables
  • Table 3. Key Players of Equipment
  • Table 4. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
  • Table 5. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 6. Global In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
  • Table 7. Global In Vitro Testing for Infectious Diseases Market Share by Region (2019-2024)
  • Table 8. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 9. Global In Vitro Testing for Infectious Diseases Market Share by Region (2025-2030)
  • Table 10. In Vitro Testing for Infectious Diseases Market Trends
  • Table 11. In Vitro Testing for Infectious Diseases Market Drivers
  • Table 12. In Vitro Testing for Infectious Diseases Market Challenges
  • Table 13. In Vitro Testing for Infectious Diseases Market Restraints
  • Table 14. Global In Vitro Testing for Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)
  • Table 15. Global In Vitro Testing for Infectious Diseases Revenue Share by Players (2019-2024)
  • Table 16. Global Top In Vitro Testing for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2023)
  • Table 17. Global In Vitro Testing for Infectious Diseases Industry Ranking 2022 VS 2023 VS 2024
  • Table 18. Global 5 Largest Players Market Share by In Vitro Testing for Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)
  • Table 19. Global Key Players of In Vitro Testing for Infectious Diseases, Headquarters and Area Served
  • Table 20. Global Key Players of In Vitro Testing for Infectious Diseases, Product and Application
  • Table 21. Global Key Players of In Vitro Testing for Infectious Diseases, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 24. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2019-2024)
  • Table 25. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 26. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2025-2030)
  • Table 27. Global In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 28. Global In Vitro Testing for Infectious Diseases Revenue Share by Application (2019-2024)
  • Table 29. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 30. Global In Vitro Testing for Infectious Diseases Revenue Share by Application (2025-2030)
  • Table 31. North America In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 32. North America In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 33. North America In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 34. North America In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 35. North America In Vitro Testing for Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. North America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 37. North America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 38. Europe In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 39. Europe In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 40. Europe In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 41. Europe In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 42. Europe In Vitro Testing for Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 43. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 44. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 45. China In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 46. China In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 47. China In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 48. China In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 49. Asia In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 50. Asia In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 51. Asia In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 52. Asia In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 53. Asia In Vitro Testing for Infectious Diseases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 54. Asia In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
  • Table 55. Asia In Vitro Testing for Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 61. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
  • Table 63. Roche Company Details
  • Table 64. Roche Business Overview
  • Table 65. Roche In Vitro Testing for Infectious Diseases Product
  • Table 66. Roche Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 67. Roche Recent Developments
  • Table 68. Siemens Company Details
  • Table 69. Siemens Business Overview
  • Table 70. Siemens In Vitro Testing for Infectious Diseases Product
  • Table 71. Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 72. Siemens Recent Developments
  • Table 73. Abbott Company Details
  • Table 74. Abbott Business Overview
  • Table 75. Abbott In Vitro Testing for Infectious Diseases Product
  • Table 76. Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 77. Abbott Recent Developments
  • Table 78. Danaher Company Details
  • Table 79. Danaher Business Overview
  • Table 80. Danaher In Vitro Testing for Infectious Diseases Product
  • Table 81. Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 82. Danaher Recent Developments
  • Table 83. Thermo Fisher Company Details
  • Table 84. Thermo Fisher Business Overview
  • Table 85. Thermo Fisher In Vitro Testing for Infectious Diseases Product
  • Table 86. Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 87. Thermo Fisher Recent Developments
  • Table 88. BioMerieux Company Details
  • Table 89. BioMerieux Business Overview
  • Table 90. BioMerieux In Vitro Testing for Infectious Diseases Product
  • Table 91. BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 92. BioMerieux Recent Developments
  • Table 93. Bio-Rad Company Details
  • Table 94. Bio-Rad Business Overview
  • Table 95. Bio-Rad In Vitro Testing for Infectious Diseases Product
  • Table 96. Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 97. Bio-Rad Recent Developments
  • Table 98. BD Company Details
  • Table 99. BD Business Overview
  • Table 100. BD In Vitro Testing for Infectious Diseases Product
  • Table 101. BD Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 102. BD Recent Developments
  • Table 103. KHB Company Details
  • Table 104. KHB Business Overview
  • Table 105. KHB In Vitro Testing for Infectious Diseases Product
  • Table 106. KHB Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 107. KHB Recent Developments
  • Table 108. Daan Gene Company Details
  • Table 109. Daan Gene Business Overview
  • Table 110. Daan Gene In Vitro Testing for Infectious Diseases Product
  • Table 111. Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 112. Daan Gene Recent Developments
  • Table 113. Leadman Company Details
  • Table 114. Leadman Business Overview
  • Table 115. Leadman In Vitro Testing for Infectious Diseases Product
  • Table 116. Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 117. Leadman Recent Developments
  • Table 118. Zhongsheng Company Details
  • Table 119. Zhongsheng Business Overview
  • Table 120. Zhongsheng In Vitro Testing for Infectious Diseases Product
  • Table 121. Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 122. Zhongsheng Recent Developments
  • Table 123. Bsbe Company Details
  • Table 124. Bsbe Business Overview
  • Table 125. Bsbe In Vitro Testing for Infectious Diseases Product
  • Table 126. Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 127. Bsbe Recent Developments
  • Table 128. Maccura Company Details
  • Table 129. Maccura Business Overview
  • Table 130. Maccura In Vitro Testing for Infectious Diseases Product
  • Table 131. Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 132. Maccura Recent Developments
  • Table 133. Hitachi Company Details
  • Table 134. Hitachi Business Overview
  • Table 135. Hitachi In Vitro Testing for Infectious Diseases Product
  • Table 136. Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 137. Hitachi Recent Developments
  • Table 138. Canon Company Details
  • Table 139. Canon Business Overview
  • Table 140. Canon In Vitro Testing for Infectious Diseases Product
  • Table 141. Canon Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 142. Canon Recent Developments
  • Table 143. Sysmex Company Details
  • Table 144. Sysmex Business Overview
  • Table 145. Sysmex In Vitro Testing for Infectious Diseases Product
  • Table 146. Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 147. Sysmex Recent Developments
  • Table 148. Auto Bio Company Details
  • Table 149. Auto Bio Business Overview
  • Table 150. Auto Bio In Vitro Testing for Infectious Diseases Product
  • Table 151. Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 152. Auto Bio Recent Developments
  • Table 153. Mindray Company Details
  • Table 154. Mindray Business Overview
  • Table 155. Mindray In Vitro Testing for Infectious Diseases Product
  • Table 156. Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 157. Mindray Recent Developments
  • Table 158. Bgi Company Details
  • Table 159. Bgi Business Overview
  • Table 160. Bgi In Vitro Testing for Infectious Diseases Product
  • Table 161. Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 162. Bgi Recent Developments
  • Table 163. Wondfo Company Details
  • Table 164. Wondfo Business Overview
  • Table 165. Wondfo In Vitro Testing for Infectious Diseases Product
  • Table 166. Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
  • Table 167. Wondfo Recent Developments
  • Table 168. Research Programs/Design for This Report
  • Table 169. Key Data Information from Secondary Sources
  • Table 170. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global In Vitro Testing for Infectious Diseases Market Share by Type: 2023 VS 2030
  • Figure 3. Consumables Features
  • Figure 4. Equipment Features
  • Figure 5. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 6. Global In Vitro Testing for Infectious Diseases Market Share by Application: 2023 VS 2030
  • Figure 7. Hepatitis Case Studies
  • Figure 8. Pneumonia Case Studies
  • Figure 9. Sexually Transmitted Diseases Case Studies
  • Figure 10. Other Case Studies
  • Figure 11. In Vitro Testing for Infectious Diseases Report Years Considered
  • Figure 12. Global In Vitro Testing for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 13. Global In Vitro Testing for Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 14. Global In Vitro Testing for Infectious Diseases Market Share by Region: 2023 VS 2030
  • Figure 15. Global In Vitro Testing for Infectious Diseases Market Share by Players in 2023
  • Figure 16. Global Top In Vitro Testing for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2023)
  • Figure 17. The Top 10 and 5 Players Market Share by In Vitro Testing for Infectious Diseases Revenue in 2023
  • Figure 18. North America In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 19. North America In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • Figure 20. North America In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • Figure 21. North America In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
  • Figure 22. United States In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 23. Canada In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 24. Europe In Vitro Testing for Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)
  • Figure 25. Europe In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • Figure 26. Europe In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • Figure 27. Europe In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
  • Figure 28. Germany In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 29. France In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 30. U.K. In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 31. Italy In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 32. Russia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 33. Nordic Countries In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 34. China In Vitro Testing for Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)
  • Figure 35. China In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • Figure 36. China In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • Figure 37. Asia In Vitro Testing for Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)
  • Figure 38. Asia In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • Figure 39. Asia In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • Figure 40. Asia In Vitro Testing for Infectious Diseases Market Share by Region (2019-2030)
  • Figure 41. Japan In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 42. South Korea In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 43. China Taiwan In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 44. Southeast Asia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 45. India In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 46. Australia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size YoY (2019-2030) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • Figure 49. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • Figure 50. Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
  • Figure 51. Brazil In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 52. Mexico In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 53. Turkey In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 54. Saudi Arabia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 55. Israel In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 56. GCC Countries In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 57. Roche Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 58. Siemens Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 59. Abbott Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 60. Danaher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 61. Thermo Fisher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 62. BioMerieux Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 63. Bio-Rad Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 64. BD Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 65. KHB Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 66. Daan Gene Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 67. Leadman Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 68. Zhongsheng Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 69. Bsbe Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 70. Maccura Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 71. Hitachi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 72. Canon Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 73. Sysmex Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 74. Auto Bio Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 75. Mindray Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 76. Bgi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 77. Wondfo Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
  • Figure 78. Bottom-up and Top-down Approaches for This Report
  • Figure 79. Data Triangulation
  • Figure 80. Key Executives Interviewed
目次

This research report focuses on the In Vitro Testing for Infectious Diseases Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Consumables
    • 1.2.3 Equipment
  • 1.3 Market by Application
    • 1.3.1 Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hepatitis
    • 1.3.3 Pneumonia
    • 1.3.4 Sexually Transmitted Diseases
    • 1.3.5 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global In Vitro Testing for Infectious Diseases Market Perspective (2019-2030)
  • 2.2 Global In Vitro Testing for Infectious Diseases Growth Trends by Region
    • 2.2.1 In Vitro Testing for Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 In Vitro Testing for Infectious Diseases Historic Market Size by Region (2019-2024)
    • 2.2.3 In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2025-2030)
  • 2.3 In Vitro Testing for Infectious Diseases Market Dynamics
    • 2.3.1 In Vitro Testing for Infectious Diseases Industry Trends
    • 2.3.2 In Vitro Testing for Infectious Diseases Market Drivers
    • 2.3.3 In Vitro Testing for Infectious Diseases Market Challenges
    • 2.3.4 In Vitro Testing for Infectious Diseases Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue In Vitro Testing for Infectious Diseases by Players
    • 3.1.1 Global In Vitro Testing for Infectious Diseases Revenue by Players (2019-2024)
    • 3.1.2 Global In Vitro Testing for Infectious Diseases Revenue Market Share by Players (2019-2024)
  • 3.2 Global In Vitro Testing for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of In Vitro Testing for Infectious Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio
    • 3.4.1 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by In Vitro Testing for Infectious Diseases Revenue in 2023
  • 3.5 Global Key Players of In Vitro Testing for Infectious Diseases Head office and Area Served
  • 3.6 Global Key Players of In Vitro Testing for Infectious Diseases, Product and Application
  • 3.7 Global Key Players of In Vitro Testing for Infectious Diseases, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 In Vitro Testing for Infectious Diseases Breakdown Data by Type

  • 4.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Type (2019-2024)
  • 4.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2025-2030)

5 In Vitro Testing for Infectious Diseases Breakdown Data by Application

  • 5.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Application (2019-2024)
  • 5.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America In Vitro Testing for Infectious Diseases Market Size (2019-2030)
  • 6.2 North America In Vitro Testing for Infectious Diseases Market Size by Type
    • 6.2.1 North America In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024)
    • 6.2.2 North America In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030)
    • 6.2.3 North America In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • 6.3 North America In Vitro Testing for Infectious Diseases Market Size by Application
    • 6.3.1 North America In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024)
    • 6.3.2 North America In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030)
    • 6.3.3 North America In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • 6.4 North America In Vitro Testing for Infectious Diseases Market Size by Country
    • 6.4.1 North America In Vitro Testing for Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
    • 6.4.3 North America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe In Vitro Testing for Infectious Diseases Market Size (2019-2030)
  • 7.2 Europe In Vitro Testing for Infectious Diseases Market Size by Type
    • 7.2.1 Europe In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024)
    • 7.2.2 Europe In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030)
    • 7.2.3 Europe In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • 7.3 Europe In Vitro Testing for Infectious Diseases Market Size by Application
    • 7.3.1 Europe In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024)
    • 7.3.2 Europe In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030)
    • 7.3.3 Europe In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • 7.4 Europe In Vitro Testing for Infectious Diseases Market Size by Country
    • 7.4.1 Europe In Vitro Testing for Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
    • 7.4.3 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China In Vitro Testing for Infectious Diseases Market Size (2019-2030)
  • 8.2 China In Vitro Testing for Infectious Diseases Market Size by Type
    • 8.2.1 China In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024)
    • 8.2.2 China In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030)
    • 8.2.3 China In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • 8.3 China In Vitro Testing for Infectious Diseases Market Size by Application
    • 8.3.1 China In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024)
    • 8.3.2 China In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030)
    • 8.3.3 China In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia In Vitro Testing for Infectious Diseases Market Size (2019-2030)
  • 9.2 Asia In Vitro Testing for Infectious Diseases Market Size by Type
    • 9.2.1 Asia In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024)
    • 9.2.2 Asia In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030)
    • 9.2.3 Asia In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • 9.3 Asia In Vitro Testing for Infectious Diseases Market Size by Application
    • 9.3.1 Asia In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024)
    • 9.3.2 Asia In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030)
    • 9.3.3 Asia In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • 9.4 Asia In Vitro Testing for Infectious Diseases Market Size by Region
    • 9.4.1 Asia In Vitro Testing for Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024)
    • 9.4.3 Asia In Vitro Testing for Infectious Diseases Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche In Vitro Testing for Infectious Diseases Introduction
    • 11.1.4 Roche Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.1.5 Roche Recent Developments
  • 11.2 Siemens
    • 11.2.1 Siemens Company Details
    • 11.2.2 Siemens Business Overview
    • 11.2.3 Siemens In Vitro Testing for Infectious Diseases Introduction
    • 11.2.4 Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.2.5 Siemens Recent Developments
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott In Vitro Testing for Infectious Diseases Introduction
    • 11.3.4 Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.3.5 Abbott Recent Developments
  • 11.4 Danaher
    • 11.4.1 Danaher Company Details
    • 11.4.2 Danaher Business Overview
    • 11.4.3 Danaher In Vitro Testing for Infectious Diseases Introduction
    • 11.4.4 Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.4.5 Danaher Recent Developments
  • 11.5 Thermo Fisher
    • 11.5.1 Thermo Fisher Company Details
    • 11.5.2 Thermo Fisher Business Overview
    • 11.5.3 Thermo Fisher In Vitro Testing for Infectious Diseases Introduction
    • 11.5.4 Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.5.5 Thermo Fisher Recent Developments
  • 11.6 BioMerieux
    • 11.6.1 BioMerieux Company Details
    • 11.6.2 BioMerieux Business Overview
    • 11.6.3 BioMerieux In Vitro Testing for Infectious Diseases Introduction
    • 11.6.4 BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.6.5 BioMerieux Recent Developments
  • 11.7 Bio-Rad
    • 11.7.1 Bio-Rad Company Details
    • 11.7.2 Bio-Rad Business Overview
    • 11.7.3 Bio-Rad In Vitro Testing for Infectious Diseases Introduction
    • 11.7.4 Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.7.5 Bio-Rad Recent Developments
  • 11.8 BD
    • 11.8.1 BD Company Details
    • 11.8.2 BD Business Overview
    • 11.8.3 BD In Vitro Testing for Infectious Diseases Introduction
    • 11.8.4 BD Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.8.5 BD Recent Developments
  • 11.9 KHB
    • 11.9.1 KHB Company Details
    • 11.9.2 KHB Business Overview
    • 11.9.3 KHB In Vitro Testing for Infectious Diseases Introduction
    • 11.9.4 KHB Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.9.5 KHB Recent Developments
  • 11.10 Daan Gene
    • 11.10.1 Daan Gene Company Details
    • 11.10.2 Daan Gene Business Overview
    • 11.10.3 Daan Gene In Vitro Testing for Infectious Diseases Introduction
    • 11.10.4 Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.10.5 Daan Gene Recent Developments
  • 11.11 Leadman
    • 11.11.1 Leadman Company Details
    • 11.11.2 Leadman Business Overview
    • 11.11.3 Leadman In Vitro Testing for Infectious Diseases Introduction
    • 11.11.4 Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.11.5 Leadman Recent Developments
  • 11.12 Zhongsheng
    • 11.12.1 Zhongsheng Company Details
    • 11.12.2 Zhongsheng Business Overview
    • 11.12.3 Zhongsheng In Vitro Testing for Infectious Diseases Introduction
    • 11.12.4 Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.12.5 Zhongsheng Recent Developments
  • 11.13 Bsbe
    • 11.13.1 Bsbe Company Details
    • 11.13.2 Bsbe Business Overview
    • 11.13.3 Bsbe In Vitro Testing for Infectious Diseases Introduction
    • 11.13.4 Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.13.5 Bsbe Recent Developments
  • 11.14 Maccura
    • 11.14.1 Maccura Company Details
    • 11.14.2 Maccura Business Overview
    • 11.14.3 Maccura In Vitro Testing for Infectious Diseases Introduction
    • 11.14.4 Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.14.5 Maccura Recent Developments
  • 11.15 Hitachi
    • 11.15.1 Hitachi Company Details
    • 11.15.2 Hitachi Business Overview
    • 11.15.3 Hitachi In Vitro Testing for Infectious Diseases Introduction
    • 11.15.4 Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.15.5 Hitachi Recent Developments
  • 11.16 Canon
    • 11.16.1 Canon Company Details
    • 11.16.2 Canon Business Overview
    • 11.16.3 Canon In Vitro Testing for Infectious Diseases Introduction
    • 11.16.4 Canon Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.16.5 Canon Recent Developments
  • 11.17 Sysmex
    • 11.17.1 Sysmex Company Details
    • 11.17.2 Sysmex Business Overview
    • 11.17.3 Sysmex In Vitro Testing for Infectious Diseases Introduction
    • 11.17.4 Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.17.5 Sysmex Recent Developments
  • 11.18 Auto Bio
    • 11.18.1 Auto Bio Company Details
    • 11.18.2 Auto Bio Business Overview
    • 11.18.3 Auto Bio In Vitro Testing for Infectious Diseases Introduction
    • 11.18.4 Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.18.5 Auto Bio Recent Developments
  • 11.19 Mindray
    • 11.19.1 Mindray Company Details
    • 11.19.2 Mindray Business Overview
    • 11.19.3 Mindray In Vitro Testing for Infectious Diseases Introduction
    • 11.19.4 Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.19.5 Mindray Recent Developments
  • 11.20 Bgi
    • 11.20.1 Bgi Company Details
    • 11.20.2 Bgi Business Overview
    • 11.20.3 Bgi In Vitro Testing for Infectious Diseases Introduction
    • 11.20.4 Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.20.5 Bgi Recent Developments
  • 11.21 Wondfo
    • 11.21.1 Wondfo Company Details
    • 11.21.2 Wondfo Business Overview
    • 11.21.3 Wondfo In Vitro Testing for Infectious Diseases Introduction
    • 11.21.4 Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
    • 11.21.5 Wondfo Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details